| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2006;81:292-297
© 2006 The Society of Thoracic Surgeons
Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan
Accepted for publication June 24, 2005.
* Address correspondence to Dr Sakao, Department of General Thoracic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan (Email: sakao{at}med.juntendo.ac.jp).
BACKGROUND: We have tried to clarify the prognostic significance of metastasis to the highest mediastinal (HM) lymph node in patients with N2 lung cancer who underwent complete dissection of superior mediastinal (including HM) lymph nodes.
METHODS: This study analyzed 53 patients with N2 nonsmall cell lung cancer who underwent surgical procedures such as lobectomy plus hilar and mediastinal node dissection (T4, neoadjuvant therapy cases were excluded). For patients whose cancer was in the left lung, we performed surgery through the median sternotomy in order to dissect superior mediastinal nodes. The clinicopathologic records of the patients were examined for prognostic factors such as age, sex, side, histology, tumor location, tumor size, clinical node (cN) number, preoperative serum carcinoembryonic antigen level, number of metastatic stations, and HM lymph node involvement.
RESULTS: A univariate analysis showed that tumor size (T1/T2-3), cN factor (cN1-2/cN0), N2 level (multiple/single), and metastasis to the HM node were significant prognostic factors. In the multivariate analysis, metastasis to the HM lymph node remained a significant prognostic factor (p = 0.026). The 3-year survival rates were 52% in patients without metastasis to the HM lymph node and 21% in patients with metastasis to the HM lymph node (p < 0.001). Furthermore, when HM nodal involvement was absent, the 5-year survival rate was 33% even in patients with multilevel N2 status, 45% in patients with cN1-2 status, and 47% in patients with pT2-3 tumor status.
CONCLUSIONS: Highest mediastinal lymph node involvement is prognostic of highly advanced N2 disease resulting in poor outcome. The results also suggest that patients with no involvement of the HM lymph node can experience acceptable postoperative outcomes even if they have multilevel N2 status, positive cN status, or T2-3 tumor status.
This article has been cited by other articles:
|
|
 |
|
  Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent N2 Disease After Induction Therapy Does Not Jeopardize Early and Medium Term Outcomes of Pneumonectomy Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Riquet, P. Bagan, F. Le Pimpec Barthes, E. Banu, F. Scotte, C. Foucault, A. Dujon, and C. Danel Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Ann. Thorac. Surg., December 1, 2007; 84(6): 1818 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-P. Perng, C.-Y. Chen, G.-C. Chang, T.-C. Hsia, N.-Y. Hsu, Y.-H. Tsai, C.-M. Tsai, C.-H. Yang, Y.-M. Chen, C.-J. Yu, et al. Revisit of 1997 TNM Staging System--Survival Analysis of 1112 Lung Cancer Patients in Taiwan Jpn. J. Clin. Oncol., January 1, 2007; 37(1): 9 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sakao, H. Miyamoto, A. Yamazaki, S. Ou, K. Shiomi, S. Sonobe, and M. Sakuraba The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 543 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Grannis Jr Invited Commentary Ann. Thorac. Surg., January 1, 2006; 81(1): 297 - 297. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
